Irkutsk
Ulan-Ude

Blagoveshchensk
Chita
Yakutsk

Birobidzhan
Vladivostok
Khabarovsk

Magadan
Yuzhno-Sakhalinsk

Anadyr
Petropavlovsk-
Kamchatsky
Moscow

This text is translated into Russian by google automatic human level neural machine.
EastRussia is not responsible for any mistakes in the translated text. Sorry for the inconvinience.
Please refer to the text in Russian as a source.

Coronavirus complication medicine will go to Russian hospitals this summer

Coronavirus complication medicine will go to Russian hospitals this summer
Photo: pixabay.ru
The drug levilimab, which was created to combat complications with COVID-19, will go to all Russian hospitals in the summer. This was reported by the developer - the biotechnological company Biocad, citing information from the Ministry of Industry and Trade.

According to RIA News, the drug was created as part of a state program to develop improved analogues of innovative drugs. Its active substance is able to control a cytokine assault, which is one of the most dangerous manifestations of a new coronavirus infection.

The main objective of the introduction of the drug is to reduce mortality from COVID-19. It was originally developed for the treatment of rheumatoid arthritis. But now he is showing positive results in patients with moderate coronavirus.
October 29: current information on coronavirus in the Far East
Digest of regional events and latest statistics